跳至主要内容
临床试验/IRCT20200825048515N49
IRCT20200825048515N49尚未招募3 期

Evaluation of the effect of edible herbal medicine (containing Colchicum autumnale, Olea Europaea, Nigella sativa, Lavandula angustifolia, Zingiber officinale) in decreasing mortality and hospitalization duration in a severe and critical phase of patients with COVID-19.

Esfahan University of Medical Sciences0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 80 years(—)
性别
All

入选标准

  • Age range 80-40 years
  • Weight over 50 kg
  • Definite infection with COVID-19 according to diagnostic criteria
  • The acute and critical phase of COVID-19 disease who are admitted to the infectious diseases and intensive care unit.
  • Satisfaction to participate in the study

排除标准

  • Breastfeeding
  • Existence of active ulcers in the gastrointestinal tract
  • Patients taking digoxin
  • Patients who have been hospitalized before the start of the study
  • History of allergies to medicinal plants

研究者

相似试验